Cargando…
Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club
Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate ante...
Autores principales: | Wu, Eugene B., Brilakis, Emmanouil S., Lo, Sidney, Kalyanasundaram, Arun, Mashayekhi, Kambis, Kao, Hsien‐Li, Lim, Soo‐Teik, Ge, Lei, Chen, Ji‐Yan, Qian, Jie, Lee, Seung‐Whan, Harding, Scott A., Tsuchikane, Etsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754104/ https://www.ncbi.nlm.nih.gov/pubmed/31769597 http://dx.doi.org/10.1002/ccd.28607 |
Ejemplares similares
-
Device entrapment during percutaneous coronary intervention
por: Sanz‐Sánchez, Jorge, et al.
Publicado: (2022) -
First successful implementation of subintimal transcatheter withdrawal technique in intravascular ultrasound–guided tip detection antegrade dissection and reentry: a case report
por: Kitani, Shunsuke, et al.
Publicado: (2023) -
Initial clinical experience of CrossBoss catheter for in-stent chronic total occlusion lesions: A case report
por: Zhao, Lei, et al.
Publicado: (2016) -
Japanese multicenter registry evaluating the antegrade dissection reentry with cardiac computerized tomography for chronic coronary total occlusion
por: Habara, Maoto, et al.
Publicado: (2021) -
Antegrade Chronic Total Occlusion Strategies: A Technical Focus for 2020
por: Creaney, Calum, et al.
Publicado: (2020)